State Stem Cell Agency Standards Working Group Agenda 9/17/09

Day 1
Sep 17, 2009
Main Location: 

Westin San Francisco Market Street
50 Third Street
San Francisco, CA 94103

Day 2
Sep 18, 2009
Main Location: 

Westin San Francisco Market Street
50 Third Street
San Francisco, CA 94103

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

California State Stem Cell Agency

MEETING NOTICE and AGENDA
REGULAR MEETING of the
SCIENTIFIC AND MEDICAL ACCOUNTABILITY STANDARDS WORKING GROUP
OF THE INDEPENDENT CITIZENS OVERSIGHT COMMITTEE
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant to the
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

 

Thursday, September 17

1. Presentation and Discussion of Stem Cell Policy Developments

  • Scientific developments relating to iPS and gamete development
  • FDA regulation of stem cell based products
  • NY State Stem Cell Science policy on donor compensation (Robert Klitzman, M.D.)

Friday, September 18

1. Welcome from Co-chairs
2. Call to Order & Roll Call
3. Staff Report

  • Update from NIH regarding NIH Guidelines for Human Stem Cell Research

4. Consideration of CIRM MES Regulations

  • Summary of Responses to public comment on revisions
  • Options for harmonizing CIRM regulations with NAS/NIH/CA policy

5. Adjournment

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov.

Transcripts: 

© 2013 California Institute for Regenerative Medicine